Bosutinib bulk supplier for pharma manufacturers

Bosutinib 100 mg, 400 mg, 500 mg Suppliers & Bulk Manufacturers

Available Forms: Tablets

Available Strengths: 100 mg, 400 mg, 500 mg

Reference Brands: Bosulif (USA)

Bosutinib is an oral tyrosine kinase inhibitor (TKI) used for the treatment of Philadelphia chromosome–positive chronic myeloid leukemia (Ph+ CML). It works by blocking the BCR-ABL kinase enzyme that promotes the growth of cancerous white blood cells. Marketed under the brand name Bosulif, it is available as film-coated tablets in 100 mg, 400 mg, and 500 mg strengths. It is indicated for patients who are newly diagnosed or resistant/intolerant to prior TKI therapy.

Get Enquiry / Request Bulk Quote

Quick Response Guaranteed | Verified Suppliers

Bosutinib — third party manufacturing & bulk supply

Bosutinib 100 mg, 400 mg, 500 mg is available through PharmaTradz for wholesale and bulk supply as well as on a third party (contract) manufacturing basis. Buyers sourcing this product generally take one of three routes:

Wholesale / bulk supply Stock or scheduled supply from an existing manufacturer. The fastest route where the product is already registered in your market.

Third party manufacturing Manufactured to your specification and packed under your own brand and label — suits distributors and brand owners building a portfolio in their market.

Dossier licensing Where a CTD, EU-CTD or ACTD dossier exists it can often be licensed for filing in your name, compressing market entry from years to months.

Indicative minimum order quantity

Bosutinib is supplied as Tablets — an oral solid dosage form, so the indicative MOQ is 200,000 units. Actual MOQ is confirmed by the allocated manufacturer against your pack presentation and destination market. See full supply terms for dossier formats, market availability and shelf life.

Manufacturers of Bosutinib listed on PharmaTradz hold site-level approvals across WHO-GMP, EU-GMP, USFDA, ANVISA and TGA, verified at onboarding.

Request a quote for Bosutinib →

Back to Listing

Frequently Asked Questions

Bosutinib is listed as Tablets in 100 mg, 400 mg, 500 mg. Further strengths and pack presentations are confirmed with the manufacturer at RFQ stage.

Bosutinib is referenced against Bosulif (USA). Reference brands are shown for identification only and remain the property of their respective trademark owners.